Free Trial

JARISLOWSKY FRASER Ltd Buys 36,867 Shares of Relx Plc (NYSE:RELX)

Relx logo with Computer and Technology background

JARISLOWSKY FRASER Ltd increased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 3.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,202,753 shares of the technology company's stock after buying an additional 36,867 shares during the quarter. JARISLOWSKY FRASER Ltd owned 0.06% of Relx worth $54,629,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Private Trust Co. NA grew its stake in Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares in the last quarter. Sage Mountain Advisors LLC grew its stake in Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock valued at $240,000 after purchasing an additional 258 shares in the last quarter. DRW Securities LLC grew its stake in Relx by 5.9% in the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after purchasing an additional 259 shares in the last quarter. Kovitz Investment Group Partners LLC grew its stake in Relx by 3.4% in the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock valued at $371,000 after purchasing an additional 267 shares in the last quarter. Finally, Marks Group Wealth Management Inc grew its stake in Relx by 1.3% in the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock valued at $1,190,000 after purchasing an additional 325 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have commented on RELX shares. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Finally, The Goldman Sachs Group started coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy".

Read Our Latest Analysis on RELX

Relx Stock Up 1.2%

Shares of RELX traded up $0.62 during trading hours on Wednesday, hitting $53.02. 562,924 shares of the company were exchanged, compared to its average volume of 710,618. The company has a market cap of $98.13 billion, a PE ratio of 28.51, a PEG ratio of 2.73 and a beta of 0.86. The firm's 50 day moving average is $50.86 and its 200-day moving average is $48.80. Relx Plc has a 52 week low of $43.28 and a 52 week high of $55.21. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, May 9th. This is an increase from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is 59.68%.

About Relx

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines